Pathways to Success Series: A Virtual Fireside Chat with Mitch Gold, CEO of Alpine Immune Sciences

We invite you to join a virtual fireside chat with Mitch Gold, CEO of Alpine Immune Sciences. Earlier this year, Alpine was acquired for $4.9 billion by Vertex Pharmaceuticals — the highest value ever paid for a biotech company at its stage of the clinical-regulatory process. 

Fenwick partners Effie Toshav and Doug Cogen will join Mitch as he shares insights on Alpine’s journey, what it takes to successfully lead a biotech in the current environment, the M&A process, and emerging trends in the life sciences industry. This is a unique opportunity to hear firsthand about the strategies that fueled Alpine’s success and the evolving landscape of biotech innovation and acquisitions. This event is the first in Fenwick’s three-part Pathways to Success webinar series.

Register for this webinar here.

About Fenwick’s Pathways to Success Series
Fenwick hosts an essential three-part webinar series designed specifically for leaders of late-stage biotech companies. This series will provide in-depth guidance on critical lifecycle moments, featuring insights from industry experts on billion-dollar acquisitions, strategic IPO planning, and emerging M&A trends set to shape 2025. Don’t miss this opportunity to prepare your company for pivotal transitions.